Iran’s demands on verification talks thwart agreement on steps to strengthen biological weapons ban.
The Biological Weapons Convention comes up for review in November. In Geneva, the states-parties debated what needs to be done to improve the treaty, which prohibits development and production of biological weapons.
An April preparatory committee meeting in Geneva addressed primarily procedural topics and heard new pledges of support as countries readied for the upcoming quinquennial review...
With the attention of many delegations starting to turn toward the 2016 review conference, the states-parties to the Biological Weapons Convention (BWC) met Dec. 1-5 in Geneva.
First Jonathan Tucker Conference on Biological and Chemical Weapon Arms Control. Discussing Syria, OPCW, and history of chemical warfare.
Four new states have acceded to the Biological Weapons Convention (BWC) since January 2013, bringing the total number of states-parties to 170.
Four years ago, President-elect Barack Obama told the country that “conventional thinking has failed to keep up with new nuclear, chemical, and biological threats.” Upon taking office, he immediately began working toward ambitious nuclear disarmament goals, making his first major foreign address a vow to “seek the peace and security of a world without nuclear weapons.”
The 1972 Biological Weapons Convention (BWC), which currently has 165 states-parties, is the principal international legal instrument against biological warfare. Developments in science and technology pose a continuing challenge to the treaty and the broader biological weapons nonproliferation regime. If they are applied to state or nonstate biological weapons programs, these developments can undermine the treaty’s prohibitions.